July 22 - 29, 2018
Snowmass Village, Colorado, USA
*as of July 17, 2018
Sunday, July 22
Welcome and Workshop Overview5:30-6 p.m.
Mark W. Geraci, Indiana University, Indianapolis, Indiana
Workshop Pre-Test6-6:30 p.m.
Welcome and Introduction of Keynote Lecture6:30-6:35 p.m.
Ross L. Levine, Memorial Sloan Kettering Cancer Center, New York, New York
Keynote LecturePreclinical Cancer Target Validation: How Not to Be Wrong William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, Massachusetts
Opening Dinner and Reception7:30-9:30 p.m.
Monday, July 23
Grant Writing Tutorial8-9 a.m.
William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, Massachusetts
Lecture: Oral Presentations that Audiences Remember9-9:50 a.m.
Michael A. Caligiuri, City of Hope, Duarte, California
Lineage Plasticity in Prostate Cancer10:10-11 a.m.
Charles L. Sawyers, Memorial Sloan Kettering Cancer Center, New York, New York
Chromatin, Epigenetics, and Cancer11-11:50 a.m.
Charles W.M. Roberts, St. Jude's Children's Research Hospital, Memphis, Tennessee
Faculty "Office Hours"11:50 a.m.-1 p.m.Sign-up will be available.
MBCO Class of 2018 Group Photograph2-2:15 p.m.
Introduction to Laboratory Sessions^2:25-2:45 p.m.
Laboratory Session Rotation #1^2:45-5:45 p.m.
Laboratory 1: miRNA Research Using qPCR TechnologyCamilla Heinzmann, Heinzmann Coaching and Consulting, Inc., Valencia, CaliforniaMaggie Soares, Heinzmann Coaching and Consulting, Inc., Toronto, Ontario, CanadaAmy Smith, QIAGEN, Inc., Germantown, Maryland
Laboratory 2: System-wide Cancer Characterization: From Protein Purification to Metabolic FluxNicholas A. Graham, University of Southern California, Los Angeles, CaliforniaParag Mallick, Stanford University, Stanford,
CaliforniaNick Hartel, University of Southern California, Los Angeles,
Laboratory 3: Next-Generation Sequencing: An Introduction and Applications for OncologyAmanda Gedman, Illumina, Inc., Raleigh, North CarolinaMargaret Porter, Illumina, Inc., San Diego, California
Laboratory 4: RNA-seq Analysis in Cancer Biomarker Discovery and Network InterpretationMichael G. Edwards, Bioinfo Solutions, Parker, ColoradoTzu Phang, University of Colorado Anschutz Medical Campus, Aurora,
ColoradoRobert Stearman, Indiana University School of Medicine, Indianapolis, Indiana
Laboratory 5: CRISPR/Cas9: The Genome Editing RevolutionLeigh Brody, Desktop Genetics, London, United Kingdom
Top of page
Tuesday, July 24
Lecture: Cell-Based Adoptive Immunotherapy – CAR T and More 8-8:50 a.m.
Carl H. June, Abramson Cancer Center of University of the Pennsylvania, Philadelphia, Pennsylvania
Lecture: Immunotherapy for Genitourinary Cancers – Laboratory and Clinical Perspectives8:50-9:40 a.m.
Charles G. Drake, Columbia University Herbert Irving Comprehensive Cancer Center, New York, New York
Understanding Responses To Cancer Therapy – The Tissue Is the Issue, but the Scoop Is in the Poop10-10:50 a.m.
Jennifer A. Wargo, The University of Texas MD Anderson Cancer Center, Houston, Texas
Hitting the Target in Clinical Trials10:50-11:40 a.m.
Jean Y. Tang, Stanford University School of Medicine, Redwood City, California
Grant Group Discussion #21-2:30 p.m.
Laboratory Session Rotation #2^2:30-5:30 p.m.
Barbecue Dinner6:30-8 p.m.
Wednesday, July 25
Laboratory Session Rotation #3^8-11 a.m.
Resistance to Molecularly Targeted Therapies – Perspectives from the Dark Side11:10 a.m.-12 p.m.
Jeffrey A. Engelman, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts
Grant Group Discussion #31:15-2:45 p.m.
Signaling and Epigenetics in Leukemia – A Sideways Journey 2:45-3:35 p.m.
Systematic Approaches to Identify and Credential Cancer Targets3:35-4:25 p.m.
William C. Hahn, Dana-Farber Cancer Institute, Boston, Massachusetts
Translational Genomics in an Age of Precision Oncology4:40-5:30 p.m.
Barry S. Taylor, Memorial Sloan Kettering Cancer Center, New York, New York
Thursday, July 26
(No lectures or laboratory sessions)
Friday, July 27
Laboratory Session Rotation #4^8-11 a.m.
Grant Group Discussion #4
11 a.m.-12:30 p.m.
Trainees: Lunch on Own / Free TimeFaculty: Faculty Meeting and Lunch12:30-2 p.m.
Faculty "Office Hours"2-3 p.m.
There and Back Again – One Journey from Bench to Bedside to Industry3-3:30 p.m.
Amanda J. Redig, Takeda Oncology, Cambridge, Massachusetts
Lecture: The Best of Both Worlds – Structure, Function, and Therapeutic Targeting of the EGF Receptor4:40-5:30 p.m.
Christine M. Lovly, Vanderbilt University Medical Center, Nashville, Tennessee
Lecture: Responsible Conduct of Research4:40-5:25 p.m.
Career Development Panel5:30-6:30 p.m.
Saturday, July 28
Laboratory Session Rotation #5^8-11 a.m.
Using Mouse Models to Study Sarcoma and Radiation Biology11:10 a.m.-12 p.m.David G. Kirsch, Duke University Medical Center, Durham, North Carolina
Lung Cancer Chemoprevention – Implications for Early Carcinogenesis12-12:50 p.m.Mark W. Geraci, Indiana University, Indianapolis, Indiana
Free Time / Working Lunch on Own12:50-2 p.m.
Funding Opportunities for Physician-Scientists2-2:30 p.m.
Faculty "Office Hours"2:30-4 p.m.
Workshop Post-Test4-4:30 p.m.
Specific Aims Recap and Closing Remarks4:30-6 p.m.
Closing Dinner and Party7-10 p.m.
Sunday, July 29
^Not eligible for CME credit